Odesivimab

• Description :

  Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection[1].

• Product Name Alternative :

  REGN-3471

• UNSPSC :

  12352203

• Target :

  Filovirus

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/odesivimab.html

• Purity :

  99.64

• Solubility :

  10 mM in DMSO

• Smiles :

  [Odesivimab]

• Molecular Weight :

  (146.16 kDa)

• References & Citations :

  [1]Markham A. REGN-EB3: First Approval. Drugs. 2021 Jan;81 (1) :175-178.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported

• CAS Number :

  [2135632-30-1]